486 related articles for article (PubMed ID: 10992360)
1. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Chen GL; Bagley DH
J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
[TBL] [Abstract][Full Text] [Related]
2. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
Boorjian S; Ng C; Munver R; Palese MA; Vaughan ED; Sosa RE; Del Pizzo JJ; Scherr DS
Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
[TBL] [Abstract][Full Text] [Related]
3. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.
Keeley FX; Bibbo M; Bagley DH
J Urol; 1997 May; 157(5):1560-5. PubMed ID: 9112476
[TBL] [Abstract][Full Text] [Related]
4. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience.
Daneshmand S; Quek ML; Huffman JL
Cancer; 2003 Jul; 98(1):55-60. PubMed ID: 12833455
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma.
Keeley FX; Kulp DA; Bibbo M; McCue PA; Bagley DH
J Urol; 1997 Jan; 157(1):33-7. PubMed ID: 8976209
[TBL] [Abstract][Full Text] [Related]
7. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
[TBL] [Abstract][Full Text] [Related]
8. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
Goel MC; Mahendra V; Roberts JG
J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
[TBL] [Abstract][Full Text] [Related]
12. Imperative indications for conservative management of upper tract transitional cell carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
[TBL] [Abstract][Full Text] [Related]
13. Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome.
Reisiger K; Hruby G; Clayman RV; Landman J
Urology; 2007 Aug; 70(2):263-6. PubMed ID: 17826486
[TBL] [Abstract][Full Text] [Related]
14. Retrograde endoscopic laser therapy and ureteroscopic surveillance for transitional cell carcinoma of the upper urinary tract.
Mugiya S; Ozono S; Nagata M; Otsuka A; Takayama T; Nagae H
Int J Urol; 2006 Jan; 13(1):1-6. PubMed ID: 16448423
[TBL] [Abstract][Full Text] [Related]
15. 13-year experience with percutaneous management of upper tract transitional cell carcinoma.
Clark PE; Streem SB; Geisinger MA
J Urol; 1999 Mar; 161(3):772-5; discussion 775-6. PubMed ID: 10022682
[TBL] [Abstract][Full Text] [Related]
16. Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma.
Hendin BN; Streem SB; Levin HS; Klein EA; Novick AC
J Urol; 1999 Mar; 161(3):783-5. PubMed ID: 10022684
[TBL] [Abstract][Full Text] [Related]
17. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic treatment of upper tract transitional cell carcinoma.
Soderdahl DW; Fabrizio MD; Rahman NU; Jarrett TW; Bagley DH
Urol Oncol; 2005; 23(2):114-22. PubMed ID: 15869996
[TBL] [Abstract][Full Text] [Related]
19. [Definitive endourological treatment in urothelial tumors of the upper urinary tract].
Rodríguez Rodríguez R; Fernández González I; Galbis Sanjuan F; Fernández Fernández E; Escudero Barrilero A; Lovaco Castellanos F
Arch Esp Urol; 1995 Nov; 48(9):937-43. PubMed ID: 8554399
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
